Profile data is unavailable for this security.
About the company
Huakang Biomedical Holdings Co Ltd is an investment holding company mainly engaged in the production and sales of in-vitro diagnostic reagents. The Company operates its business through two segments. The Biological Reagents and Auxiliary Reproductive Supplies and Equipment segment is engaged in the research and development, production, marketing and sales of in-vitro diagnostic reagents, including male infertility in vitro diagnostic reagents, parasite series detection reagents and Epstein-Barr (EB) virus detection reagents. The Segment is also engaged in the manufacture and sale of auxiliary reproductive supplies and devices. The Healthcare Products and Supplements segment is engaged in the sales of health products and supplements.
- Revenue in HKD (TTM)26.57m
- Net income in HKD-6.24m
- Incorporated2017
- Employees96.00
- LocationHuakang Biomedical Holdings Co Ltd2/F, 100 Des Voeux Road Central, Central Hong KongHKG
- Phone+852 22028989
- Fax+852 22028989
- Websitehttp://www.huakangbiomedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Huakang Biomedical Holdings Co Ltd | 26.57m | -6.24m | 49.55m | 96.00 | -- | 0.7526 | -- | 1.86 | -0.015 | -0.015 | 0.0639 | 0.1315 | 0.374 | 2.69 | 2.57 | 276,801.90 | -8.78 | -6.96 | -10.62 | -8.01 | 64.49 | 66.27 | -23.48 | -20.23 | 3.82 | -- | 0.0429 | -- | -2.77 | -3.00 | -88.03 | -- | -12.03 | -- |
| Extrawell Pharmaceutical Holdings Ltd | 68.62m | -154.28m | 86.04m | 169.00 | -- | 0.0827 | -- | 1.25 | -0.0776 | -0.0776 | 0.0209 | 0.4354 | 0.0538 | 7.47 | 9.89 | 379,132.60 | -12.00 | 4.62 | -12.50 | 4.88 | 47.36 | 51.97 | -223.07 | 73.99 | 3.38 | -0.0514 | 0.0968 | 0.00 | -1.82 | -3.28 | -1.01 | 33.99 | 121.54 | -- |
| Sanai Health Industry Group Co Ltd | 131.74m | 20.10m | 91.74m | 68.00 | 4.34 | 0.270 | 5.15 | 0.6964 | 0.0055 | 0.0055 | 0.0347 | 0.0889 | 0.3179 | 188.03 | 8.44 | 1,937,283.00 | 3.48 | 2.31 | 4.72 | 3.65 | 28.77 | 34.87 | 10.95 | 6.56 | 6.22 | -- | 0.1881 | 0.00 | -30.60 | 16.04 | -36.23 | -- | -75.21 | -- |
| China Health Group Inc | 23.12m | -62.81m | 99.54m | 42.00 | -- | 1.09 | -- | 4.31 | -0.0631 | -0.0631 | 0.0232 | 0.0919 | 0.1438 | -- | 0.246 | 550,383.10 | -39.07 | 6.84 | -51.26 | 9.52 | 38.33 | 74.98 | -271.70 | 19.19 | -- | -- | 0.00 | 0.00 | 63.67 | -18.51 | -267.82 | -- | 30.37 | -- |
| BioSino Bio-technology and Science Inc | 311.89m | -12.57m | 101.30m | 537.00 | -- | 0.4463 | -- | 0.3248 | -0.0868 | -0.0868 | 2.16 | 1.57 | 0.4956 | 2.79 | 1.46 | 580,800.30 | -3.30 | -3.84 | -8.55 | -10.17 | 44.06 | 40.17 | -6.66 | -6.98 | 0.9033 | -- | 0.3956 | -- | -22.52 | -0.9513 | -243.70 | -- | -16.58 | -- |
| Canbridge Pharmaceuticals Inc | 110.99m | -408.74m | 144.45m | 100.00 | -- | -- | -- | 1.30 | -0.9632 | -0.9632 | 0.2615 | -0.1011 | 0.1875 | 4.16 | 4.09 | 1,109,907.00 | -69.04 | -- | -154.20 | -- | 62.37 | -- | -368.26 | -- | 0.6132 | -41.34 | 1.39 | -- | 30.26 | -- | 21.64 | -- | -- | -- |
| Regent Pacific Group Ltd | 2.48m | -195.62m | 155.31m | 17.00 | -- | -- | -- | 62.74 | -0.8689 | -0.8689 | 0.011 | -0.053 | 0.0218 | -- | 12.19 | 145,620.50 | -172.08 | -50.00 | -694.26 | -59.04 | -- | -- | -7,901.89 | -2,685.21 | -- | -- | -- | -- | 574.47 | -44.72 | 31.24 | -- | -50.60 | -- |
| Kontafarma China Holdings Ltd | 809.11m | -28.84m | 201.19m | 720.00 | -- | 0.1903 | 4.55 | 0.2487 | -0.0052 | -0.0052 | 0.145 | 0.1892 | 0.4206 | 3.22 | 7.03 | 1,123,760.00 | -3.18 | -1.33 | -4.22 | -2.18 | 58.25 | 54.70 | -7.55 | -4.12 | 1.28 | -17.16 | 0.2392 | -- | -9.50 | -17.32 | 66.02 | -- | -19.55 | -- |
| Modern Chinese Medicine Group Co Ltd | 371.23m | 52.65m | 234.00m | 191.00 | 4.44 | 0.4586 | 3.95 | 0.6303 | 0.0878 | 0.0878 | 0.6187 | 0.8504 | 0.6681 | 5.45 | 3.80 | 1,943,629.00 | 9.47 | 20.76 | 10.75 | 25.82 | 30.28 | 41.02 | 14.18 | 20.11 | 7.98 | 206.12 | 0.0002 | 2.54 | -13.91 | 14.67 | -44.44 | 0.2303 | 96.96 | -- |
| Wai Yuen Tong Medicine Holdings Limited | 1.36bn | 36.42m | 243.02m | 1.96k | 7.14 | 0.1137 | 1.42 | 0.1788 | 0.0303 | 0.0303 | 1.13 | 1.90 | 0.2014 | 0.424 | 22.81 | 700,208.60 | 0.8907 | -0.0733 | 1.54 | -0.1196 | 49.08 | 42.52 | 4.42 | -0.456 | 0.5663 | 1.49 | 0.3196 | 0.00 | -7.55 | 8.75 | 81.16 | -- | -12.06 | -- |
Data as of Jun 14 2024. Currency figures normalised to Huakang Biomedical Holdings Co Ltd's reporting currency: Hong Kong Dollar HKD
